Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
27
|
pubmed:dateCreated |
1997-7-31
|
pubmed:abstractText |
The hepatitis B viral X promoter is known to be positively autoregulated by its own HBx protein, which also interacts with many cellular regulatory proteins. We investigated the effect of activating transcription factor 2 (ATF2) on the activity of the X promoter. Cotransfection of the ATF2 expression vector with a X promoter-chloramphenicol acetyltransferase plasmid repressed the X promoter activity in HepG2 cells. HBx activated activating protein 1 (AP-1)-mediated transcription through the hepatitis B virus E element by 35-fold, while its activation activity was inhibited in the presence of ATF2, suggesting that ATF2 inhibited the autoactivation of X promoter by HBx and basal transcription mediated by AP-1. Since the binding sites of AP-1 and ATF2 in the hepatitis B virus E element overlap, the repression of X promoter activity by ATF2 is exerted by the competition for the AP-1 binding site and the formation of the ATF2-Jun heterodimer as in the case of the consensus AP-1 element. However, the small X promoter had a ATF2 binding site and was activated by ATF2. These results suggest that the syntheses of X proteins are differentially regulated by ATF2.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ATF2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Activating Transcription Factor 2,
http://linkedlifedata.com/resource/pubmed/chemical/Chloramphenicol O-Acetyltransferase,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP Response...,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-jun,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
272
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
16934-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9202004-Activating Transcription Factor 2,
pubmed-meshheading:9202004-Binding, Competitive,
pubmed-meshheading:9202004-Binding Sites,
pubmed-meshheading:9202004-Chloramphenicol O-Acetyltransferase,
pubmed-meshheading:9202004-Cyclic AMP Response Element-Binding Protein,
pubmed-meshheading:9202004-Dimerization,
pubmed-meshheading:9202004-Down-Regulation,
pubmed-meshheading:9202004-Enhancer Elements, Genetic,
pubmed-meshheading:9202004-Hepatitis B virus,
pubmed-meshheading:9202004-Humans,
pubmed-meshheading:9202004-Leucine Zippers,
pubmed-meshheading:9202004-Promoter Regions, Genetic,
pubmed-meshheading:9202004-Proto-Oncogene Proteins c-jun,
pubmed-meshheading:9202004-Transcription Factors,
pubmed-meshheading:9202004-Tumor Cells, Cultured
|
pubmed:year |
1997
|
pubmed:articleTitle |
Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer.
|
pubmed:affiliation |
Department of Molecular Biology and Research Center for Cell Differentiation, Seoul National University, Seoul 151-742, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|